Cheryl Rockman-Greenberg (born September 26, 1950) is a Canadian physician and educator.
She was born in Montreal and received a MDCM from McGill University in 1974.
In 1979, she began work as a clinical and metabolic geneticist for the Winnipeg Regional Health Authority.
[1] Rockman-Greenberg is the leading Canadian researcher in the treatment of hypophosphatasia.
She also developed targeted DNA-based screening programs for newborns in Manitoba for a number of rare conditions including glutaric aciduria type 1 in the Oji-Cree and carnitine palmitoyltransferase I deficiency in Hutterites; these screening programs were aimed at groups with higher incidence of these conditions than the general population.